Holen Sie sich die Stockscreener-App
4.04
0.49%
-0.02
Handel nachbörslich:
4.11
0.07
+1.73%
Schlusskurs vom Vortag:
$4.06
Offen:
$4.1
24-Stunden-Volumen:
7,882
Relative Volume:
0.08
Marktkapitalisierung:
$10.97M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-8.09M
KGV:
-24.97
EPS:
-0.1618
Netto-Cashflow:
$-8.31M
1W Leistung:
-4.27%
1M Leistung:
-31.99%
6M Leistung:
-33.66%
1J Leistung:
-89.56%
1-Tages-Spanne:
$3.98
$4.1099
1-Wochen-Bereich:
$3.98
$5.085
52-Wochen-Spanne:
$3.78
$42.90
Abpro Holdings Inc Stock (ABP) Company Profile
Firmenname
Abpro Holdings Inc
Sektor
Branche
Telefon
248-890-7200
Adresse
6 ST JOHNS LANE, FLOOR 5, NEW YORK
Vergleichen Sie ABP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ABP
Abpro Holdings Inc
|
4.04 | 11.03M | 0 | -8.09M | -8.31M | -0.1618 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.86 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
796.55 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
398.29 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
788.49 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.97 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Abpro Holdings Inc Aktie (ABP) Neueste Nachrichten
Abpro secures NASDAQ extension to regain compliance with listing rules - MSN
How Abpro Holdings Inc. stock compares to industry benchmarksLayoff News & Daily Profit Focused Screening - ulpravda.ru
Maxim Group Initiates Coverage of Abpro Holdings (ABP) with Buy Recommendation - MSN
Abpro Holdings, IncCommon Stock (NQ: ABP - FinancialContent
Why Abpro Holdings Inc. stock is a value investor pickWeekly Trade Summary & High Accuracy Investment Entry Signals - ulpravda.ru
Market Rankings: Can Abpro Holdings Inc Equity Warrant stock outperform in 2025 bull marketShare Buyback & Weekly High Return Stock Forecasts - moha.gov.vn
How institutional buying supports Abpro Holdings Inc. Equity Warrant stock2025 Major Catalysts & Accurate Trade Setup Notifications - ulpravda.ru
Can Abpro Holdings Inc. Equity Warrant stock outperform in 2025 bull marketWeekly Trade Report & Safe Capital Growth Tips - ulpravda.ru
Is Orchestra BioMed Holdings Inc. stock a dividend growth opportunityJuly 2025 Update & Daily Chart Pattern Signal Reports - ulpravda.ru
What momentum indicators show for Abpro Holdings Inc. stockJuly 2025 PreEarnings & Growth Oriented Trade Recommendations - ulpravda.ru
FDA clears Abpro and Celltrion’s solid tumor therapy for clinical trial - Investing.com Nigeria
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
FDA clears Abpro’s lead HER2 cancer drug for phase 1 - MSN
Abpro stock rises after FDA clearance for solid tumor program By Investing.com - Investing.com South Africa
Abpro stock rises after FDA clearance for solid tumor program - Investing.com
FDA clears Abpro and Celltrion’s solid tumor therapy for clinical trial By Investing.com - Investing.com South Africa
FDA Clears Abpro’s Lead HER2 Cancer Drug for Phase 1 - TipRanks
Abpro and Celltrion, Inc. Announce U.S. FDA IND Clearance for Lead Multispecific Antibody Cancer Candidate ABP-102 / CT-P72 - The Manila Times
Abpro and Celltrion, Inc. Announce U.S. FDA IND Clearance - GlobeNewswire
Published on: 2025-12-30 01:00:17 - moha.gov.vn
Aug Levels: Why Abpro Holdings Inc stock could rally in 2025July 2025 Price Swings & AI Forecasted Entry/Exit Points - moha.gov.vn
Abpro Holdings Inc. (NASDAQ:ABP) Short Interest Update - Defense World
Aug Selloffs: How Abpro Holdings Inc. Equity Warrant stock reacts to job market dataTrade Volume Report & Fast Gain Stock Tips - Улправда
How Abpro Holdings Inc. Equity Warrant stock valuations compare to rivalsQuarterly Profit Report & Expert Curated Trade Ideas - Улправда
Is Abpro Holdings Inc. Equity Warrant stock a smart buy before Fed meetingTrade Risk Assessment & Weekly Momentum Picks - Улправда
How Abpro Holdings Inc. Equity Warrant stock benefits from tech adoptionQuarterly Trade Report & Free Weekly Watchlist of Top Performers - Улправда
Net current asset value per share of Abpro Holdings, Inc. Warrant 2024-12.11.29 on Abpro Hldgs – NASDAQ:ABPWW - TradingView — Track All Markets
How Abpro Holdings Inc. Equity Warrant stock reacts to job market dataJuly 2025 Trade Ideas & AI Driven Price Predictions - Улправда
Can Abpro Holdings Inc. Equity Warrant stock rebound after recent weaknessQuarterly Trade Summary & Free Growth Oriented Trading Recommendations - Улправда
What Wall Street predicts for Abpro Holdings Inc. stock priceTrade Performance Summary & Daily Growth Stock Investment Tips - DonanımHaber
Why Abpro Holdings Inc. Equity Warrant stock remains undervalued - Улправда
How interest rate cuts could boost Abpro Holdings Inc. stockWeekly Profit Report & Safe Capital Growth Plans - DonanımHaber
Abpro (NASDAQ:ABP) Stock Price Up 0.2% – Still a Buy? - Defense World
Chipmakers Recap: How Abpro Holdings Inc. stock compares to industry benchmarks2025 Volatility Report & Target Return Focused Stock Picks - Улправда
Abpro Hldgs (ABP) Stock Analysis Report | Financials & Insights - Benzinga
Aug Patterns: How Abpro Holdings Inc. Equity Warrant stock valuations compare to rivals2025 Market Sentiment & AI Forecasted Stock Moves - ulpravda.ru
Abpro and Celltrion announce IND filing for T-cell engager - BioWorld MedTech
Abpro Holdings submits IND application for Phase 1 trial of ABP102/CT-P72 - TipRanks
Abpro Holdings Submits IND Application for Cancer Drug - TipRanks
Abpro Holdings, Inc. Submits IND for Phase 1 Trial of ABP-102/CT-P72 - TradingView — Track All Markets
Abpro Holdings (NASDAQ: ABP) discloses IND filing for HER2 therapy - Stock Titan
Abpro Holdings announces submission of an IND application to initiate a Phase 1 clinical trial of T cell engager ABP-102/CT-P72 for HER2-positive cancers - marketscreener.com
Abpro Holdings Announces Submission of an IND Application to Initiate a Phase 1 Clinical Trial of T cell engager ABP-102/CT-P72 for HER2-positive Cancers - TradingView — Track All Markets
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Abpro Holdings Announces Submission of an IND Application - GlobeNewswire
Abpro Holdings Granted Nasdaq Compliance Extension - TipRanks
Abpro Holdings granted Nasdaq compliance extension - MSN
Abpro Holdings, Inc. Granted Nasdaq Listing Extension - TradingView — Track All Markets
Abpro Granted Nasdaq Listing Extension to Pursue Compliance and Strategic Objectives - marketscreener.com
Fed Watch: Will Abpro Holdings Inc stock reach all time highs in 2025Trade Entry Report & Fast Momentum Stock Entry Tips - moha.gov.vn
What catalysts could drive Abpro Holdings Inc. stock higherFed Meeting & High Return Stock Watch Alerts - Newser
Finanzdaten der Abpro Holdings Inc-Aktie (ABP)
Umsatz
Nettogewinn
Free Cashflow
ENV
Abpro Holdings Inc-Aktie (ABP) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Suk Jin Wook (Miles) | CEO and Chairman |
May 19 '25 |
Buy |
0.26 |
16,200 |
4,212 |
146,477 |
| Suk Jin Wook (Miles) | CEO and Chairman |
Apr 29 '25 |
Buy |
0.25 |
4,325 |
1,081 |
130,277 |
| Suk Jin Wook (Miles) | CEO and Chairman |
Apr 24 '25 |
Buy |
0.34 |
26,542 |
9,024 |
125,902 |
| Suk Jin Wook (Miles) | CEO and Chairman |
Apr 23 '25 |
Buy |
0.28 |
7,460 |
2,089 |
99,360 |
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):